RB 2:ADMISSION OF 132,000,000 SHARES IN THE COMPANY TO TRADING ON THE WSE
Firma: SOPHARMA ADSpis treści:
1. RAPORT BIEŻĄCY
2. MESSAGE (ENGLISH VERSION)
3. INFORMACJE O PODMIOCIE
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| | Raport bieżący nr | 2 | / | 2011 | | |||||||
| Data sporządzenia: | 2011-11-24 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| SOPHARMA AD | ||||||||||||
| Temat | ||||||||||||
| ADMISSION OF 132,000,000 SHARES IN THE COMPANY TO TRADING ON THE WSE | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of SOPHARMA AD (the "Company") informs that on 23 November 2011, in accordance with resolution No. 1422/2011, the Management Board of the Warsaw Stock Exchange admitted all of the shares in the share capital of the Company, i.e. 132,000,000 ordinary bearer shares in the Company to trading on the main market of the Warsaw Stock Exchange. The Company's intention is that trading in its shares on the Warsaw Stock Exchange commences on 28 November 2011. The Company’s shares were registered in the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) under ISIN code BG11SOSOBT18. This material does not constitute an offer to sell, or an invitation or a solicitation of an offer to subscribe for or to buy any securities of the Company. The prospectus in English and its Polish summary constitute the sole and only legally binding documents containing information about the Company, its operations and shares in the context of their admission and introduction to trading on the regulated market operated by the Warsaw Stock Exchange and have been published and are available on the Company’s website (www.sopharma.bg) and on the website of WOOD & Co. Financial Services as (www.wood.com). No offering of the Company’s securities is carried out on the basis of the prospectus in any jurisdiction, including Poland and Bulgaria. This material is not for distribution, directly or indirectly, in or into the United States, or in other countries where the public dissemination of the information contained herein may be restricted or prohibited by law. | ||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
| | |||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2011-11-24 | Ognian Donev | Chairman of the Board of Directors | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
